November 2017 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for November 2017. This roundup includes...
Fat Intake Influences HbA1c-Lowering Effect in DPP4i Therapy
Saturated fat intake is significantly correlated with change in HbA1c during DPP4i monotherapy
Almonds With/Without Chocolate May Improve Lipid Profiles
Findings based on a small study assessing diet combinations in overweight people
Evidence Lacking for Prenatal Vitamin D Supplementation
Although linked to increased mean birth weight, reduced risk of SGA
More Than Half Today’s Children Expected to Be Obese at 35
Relative risk of adult obesity increases with age and BMI, up to 3.10 for 19-year-olds with severe obesity
Severe Hypoglycemia a Potent Marker of Cardiovascular Risk
Findings based on long-term follow-up of patients with diabetes
Mean Serum Allopregnanolone Low Across Weight Extremes
Also tied to increased depression and anxiety severity, independent of body mass index
Endocrine-Disrupting Chemicals Linked to Diabetes Disparities
Exposure to diabetes-associated environmental EDCs may contribute to racial, socioeconomic disparities
Over 5 Percent of Incident Cancer Due to Diabetes, High BMI
In 2012, 5.6 percent of all incident cancers due to combined effects of diabetes, high BMI
Many Seniors Have Not Discussed Avoiding Drug Interactions
69 percent of patients see multiple doctors, 21 percent use multiple pharmacies, complicating issue
